Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carrier systems for bone morphogenetic proteins.

S R Winn1, H Uludag, J O Hollinger

  • 1Division of Plastic and Reconstructive Surgery, Oregon Health Sciences University, Portland 97201-3098, USA.

Clinical Orthopaedics and Related Research
|November 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.

Cancer gene therapy·2013
Same author

Specific effects of PEGylation on gene delivery efficacy of polyethylenimine: interplay between PEG substitution and N/P ratio.

Acta biomaterialia·2012
Same author

Recombinant vascular endothelial growth factor165 gene therapy improves anastomotic healing in an animal model of ischemic esophagogastrostomy.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2011
Same author

Intraventricular encapsulated calf adrenal chromaffin cells: viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats.

Restorative neurology and neuroscience·2011
Same author

The effects of ethylene oxide sterilization on the in vitro cytotoxicity of a bone replacement material.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

[Refined adenoviral transduction for controlled gene transfer into human adult mesenchymal stem cells].

Zeitschrift fur Orthopadie und ihre Grenzgebiete·2005
Same journal

Impact Microindentation Evaluates Bone Strength, Bone Quality, and Fracture Susceptibility Across Skeletal Sites: A Cadaver Study.

Clinical orthopaedics and related research·2026
Same journal

What Is the Effect of Robot Reduction in Displaced Pelvic Fractures? A Multicenter Randomized Clinical Trial.

Clinical orthopaedics and related research·2026
Same journal

CORR Insights®: Acute or Delayed TKA for Tibial Plateau Fracture? An Observational Study From the Swedish Arthroplasty Register.

Clinical orthopaedics and related research·2026
Same journal

Reply to the Letter to the Editor: Guest Editorial: Recalling a Recall.

Clinical orthopaedics and related research·2026
Same journal

Radial Head Fractures Cluster in the Anterolateral and Anteromedial Quadrants and Do Not Correlate With Coronoid Fracture Types.

Clinical orthopaedics and related research·2026
Same journal

Reduced Cerebellar Activation With Eyes Closed Is Associated With Delayed Peroneal Reaction Time in Patients With Chronic Ankle Instability.

Clinical orthopaedics and related research·2026
See all related articles

Bone morphogenetic proteins (BMPs) delivered via carriers like collagen, polylactide, or deorganified bone show varied release kinetics. Carrier properties significantly influence BMP-2 release, impacting bone regeneration outcomes.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Orthopedic Surgery

Background:

  • Critical-sized bone defects often fail to heal, leading to complications like non-union and fibrosis.
  • Traditional bone defect treatments, including autografts and allografts, have limitations.
  • Biomimetic scaffolds combined with osteogenic factors offer promising alternatives for bone regeneration.

Purpose of the Study:

  • To evaluate the pharmacokinetic profiles of recombinant human bone morphogenetic protein-2 (rhBMP-2) when delivered using different carrier systems.
  • To determine how carrier material properties influence the release kinetics of rhBMP-2.
  • To assess the impact of carrier-mediated release on potential clinical outcomes in bone regeneration.

Main Methods:

  • rhBMP-2 was loaded onto three distinct carrier systems: type I collagen sponge, poly(D,L-lactide) (PDLLA), and deorganified bovine bone (DBB).

Related Experiment Videos

  • The release kinetics of rhBMP-2 from each carrier were characterized using a rat ectopic bone formation assay.
  • Pharmacokinetic parameters, including release rate and retention, were analyzed for each carrier system.

    • Main Results:

    • Type I collagen sponges demonstrated sustained release of rhBMP-2.
    • Deorganified bovine bone exhibited an initial burst release followed by irreversible binding of rhBMP-2.
    • Poly(D,L-lactide) systems showed a dose-dependent sustained release pattern of rhBMP-2.

    Conclusions:

    • The physicochemical properties of implant carriers critically influence the release kinetics of rhBMP-2.
    • Carrier selection is a key factor in optimizing rhBMP-2 delivery for effective bone regeneration.
    • Understanding these release dynamics is crucial for improving the clinical efficacy of BMP-based therapies for bone defects.